EP3956326
(R)-3-(3-CHLORO-5-FLUORO-2-((4-(1H-PYRAZOL-1-YL)-2-METHYLQUINOLIN-8-YLOXY)METHYL)PHENYL)MORPHOLINE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ (BK) B2 RECEPTOR ANTAGONIST FOR TREATING SKIN DISEASE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
25.5.2020EP published:
28.6.2023EP application number:
20732117.5
EPO information:
European Patent Register
Max expiry date:
24.5.2040
Title in English:
(R)-3-(3-CHLORO-5-FLUORO-2-((4-(1H-PYRAZOL-1-YL)-2-METHYLQUINOLIN-8-YLOXY)METHYL)PHENYL)MORPHOLINE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ (BK) B2 RECEPTOR ANTAGONIST FOR TREATING SKIN DISEASELanguage of the patent:
English
Timeline
Today
25.5.2020EP application
28.6.2023EP Publication
Owner
Name:
Pharvaris GmbHAddress:
Grafenauweg 8, 6300 Zug, CH
Inventor
Name:
GIBSON, ChristophAddress:
13189 Berlin, DE
Name:
SAUPE, JoernAddress:
14469 Potsdam, DE
Name:
AMBROSI, Horst-DieterAddress:
10319 Berlin, DE
Name:
HAUSTEDT, Lars OleAddress:
14612 Falkensee, DE
Priority
Number:
19176229Date:
23.5.2019Country:
EP
Classification
Categories:
C07D 413/14, A61K 31/4709, A61K 31/5377, A61K 31/4155, A61K 31/4196, A61K 31/422, A61P 1/16, A61P 5/00, A61P 9/00, A61P 11/00, A61P 13/00, A61P 13/12, A61P 15/00, A61P 17/00, A61P 25/00